ATE361303T1 - N,n-dimethylierte n-invertierte porphyrine - Google Patents
N,n-dimethylierte n-invertierte porphyrineInfo
- Publication number
- ATE361303T1 ATE361303T1 AT03700767T AT03700767T ATE361303T1 AT E361303 T1 ATE361303 T1 AT E361303T1 AT 03700767 T AT03700767 T AT 03700767T AT 03700767 T AT03700767 T AT 03700767T AT E361303 T1 ATE361303 T1 AT E361303T1
- Authority
- AT
- Austria
- Prior art keywords
- dimethylated
- porphyrins
- confused
- inverted
- inverted porphyrins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35295602P | 2002-01-29 | 2002-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE361303T1 true ATE361303T1 (de) | 2007-05-15 |
Family
ID=27663158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03700767T ATE361303T1 (de) | 2002-01-29 | 2003-01-29 | N,n-dimethylierte n-invertierte porphyrine |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20040019095A1 (de) |
| EP (1) | EP1470127B1 (de) |
| JP (1) | JP2005526716A (de) |
| AT (1) | ATE361303T1 (de) |
| AU (1) | AU2003202369B2 (de) |
| CA (1) | CA2474593A1 (de) |
| DE (1) | DE60313577T2 (de) |
| DK (1) | DK1470127T3 (de) |
| ES (1) | ES2285086T3 (de) |
| PT (1) | PT1470127E (de) |
| WO (1) | WO2003064426A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070093463A1 (en) * | 2004-05-20 | 2007-04-26 | Brookhaven Science Associates, Llc | Radiation enhancement agent for X-ray radiation therapy and boron neutron-capture therapy |
| US8287839B2 (en) * | 2006-12-04 | 2012-10-16 | Brookhaven Science Associates, Llc | Carboranylporphyrins and uses thereof |
| US8444953B2 (en) * | 2007-03-22 | 2013-05-21 | Brookhaven Science Associates, Llc | Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof |
| US20080279781A1 (en) * | 2007-05-10 | 2008-11-13 | Brookhaven Science Associates, Llc | Glycosylated Carboranylporphyrins and Uses Thereof |
| CN113307814A (zh) * | 2021-06-18 | 2021-08-27 | 宜春学院 | 一种水溶性羧基n-错位卟啉及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0001455D0 (en) * | 2000-01-21 | 2000-03-15 | Scotia Holdings Plc | Porphyrins and related compounds |
-
2003
- 2003-01-28 US US10/353,787 patent/US20040019095A1/en not_active Abandoned
- 2003-01-29 JP JP2003564049A patent/JP2005526716A/ja active Pending
- 2003-01-29 EP EP03700767A patent/EP1470127B1/de not_active Expired - Lifetime
- 2003-01-29 CA CA002474593A patent/CA2474593A1/en not_active Abandoned
- 2003-01-29 DK DK03700767T patent/DK1470127T3/da active
- 2003-01-29 ES ES03700767T patent/ES2285086T3/es not_active Expired - Lifetime
- 2003-01-29 AU AU2003202369A patent/AU2003202369B2/en not_active Expired - Fee Related
- 2003-01-29 AT AT03700767T patent/ATE361303T1/de not_active IP Right Cessation
- 2003-01-29 PT PT03700767T patent/PT1470127E/pt unknown
- 2003-01-29 DE DE60313577T patent/DE60313577T2/de not_active Expired - Fee Related
- 2003-01-29 WO PCT/CA2003/000120 patent/WO2003064426A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES2285086T3 (es) | 2007-11-16 |
| DK1470127T3 (da) | 2007-09-17 |
| CA2474593A1 (en) | 2003-08-07 |
| JP2005526716A (ja) | 2005-09-08 |
| US20040019095A1 (en) | 2004-01-29 |
| EP1470127A1 (de) | 2004-10-27 |
| AU2003202369B2 (en) | 2009-01-29 |
| DE60313577T2 (de) | 2007-12-27 |
| WO2003064426A1 (en) | 2003-08-07 |
| DE60313577D1 (de) | 2007-06-14 |
| EP1470127B1 (de) | 2007-05-02 |
| PT1470127E (pt) | 2007-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE387450T1 (de) | Meso-substituierte porphyrine | |
| ATE552260T1 (de) | Substituierte porphyrine und deren therapeutische verwendung | |
| PT1420824E (pt) | Clorinas sulfonadas como fotossensibilizadores | |
| ATE489050T1 (de) | Photochemische gewebeverbindung | |
| BRPI0412348A (pt) | derivados de piperazina e seu uso como agentes terapêuticos | |
| CA2335514A1 (en) | Alkyl ether analogs of chlorins having an n-substituted imide ring | |
| DE59807044D1 (de) | 5-(4-Hydroxyphenyl)-porphyrinderivate als Photosensibilisatoren | |
| DK1381611T3 (da) | Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik | |
| ATE316134T1 (de) | Zusammensetzung mit alpha-glycosylceramid zur stärkung zellulärer immunogenität | |
| Stockert et al. | Photodynamic damage to HeLa cell microtubules induced by thiazine dyes | |
| DE60313577D1 (de) | N,n-dimethylierte n-invertierte porphyrine | |
| CY1111734T1 (el) | Χρηση παραγωγου αμιδιου του παραγοντα a3 του ge 2270 για την αγωγη της ακμης | |
| DE69819318D1 (de) | Ein klasse von benzoporphyrin derivate photowirksame verbindungen | |
| DE60315288D1 (de) | Cyanoguanidin prodrugs | |
| CO5011066A1 (es) | Compuestos de triazina | |
| DE60100704D1 (de) | Porphyrine und verwandte verbindungen | |
| RU99125040A (ru) | Сульфозамещенные фталоцианины как фотосенсибилизаторы для фотодинамической терапии | |
| TW200725181A (en) | Positive resist composition and pattern forming method using the same | |
| EA200501256A1 (ru) | НОВЫЙ СПОСОБ СИНТЕЗА (2S,3aS,7aS)-ПЕРГИДРОИНДОЛ-2-КАРБОНОВОЙ КИСЛОТЫ И ЕЁ СЛОЖНЫХ ЭФИРОВ, А ТАКЖЕ ИХ ПРИМЕНЕНИЕ ДЛЯ СИНТЕЗА ПЕРИНДОПРИЛА | |
| RU2000103198A (ru) | Окта-4,5-карбоксифталоцианины как фотосенсибилизаторы для фотодинамической терапии | |
| Wen | The applications of laser spectroscopy in analytical chemistry and biochemistry: investigating the photophysics of hypericin and hypocrellin, as well as the structure of porcine fructose-1, 6-bisphosphatase | |
| ECSP972204A (es) | Pirroles sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1470127 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |